“Immune-Directed Therapy for Type 1 Diabetes at the Clinical Level: The Immune Tolerance Network (ITN) Experience”. 2023. The Review of Diabetic Studies 9 (4). https://diabeticstudies.org/index.php/RDS/article/view/185.